www.istockphoto.com/YuriVenture StudiosEurope’s distinct biotech venture studio modelFor decades, biotech companies were formed around a discovery: a promising biological signal, a novel target, a platform emerging from academic research. Now a different formation model is gaining momentum: … more ➔
SLASEventSLAS Announces the Cohort for Innovation AveNEW at SLAS Europe 2026Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, 19-21 May 2026 more ➔
VanessaSpencer - stock.adobe.comBiotech ClusterPortugal’s biotech industry is growing upFor years, Portugal sat just outside Europe’s main biotech conversation: scientifically credible, strong in research, but too small, too fragmented and too thinly financed to compete with the established … more ➔
Kelli McClintock auf UnsplashStartups10 European Startups to watch in 2026Ten young European biotechs are heading into 2026 with the kind of momentum that can quickly turn promising science into defining data: first clinical entries, platform-to-pipeline transitions, and funding … more ➔
CencoraBest PracticeMitigating regulatory risk with holistic CMC strategiesAs advanced therapeutic medicinal products (ATMPs) and other next-generation biologics move toward approval, Chemistry, Manufacturing and Controls (CMC) continues to be the most frequent source of regulatory … more ➔
Boehmert & BoehmertIntellectual PropertyIs the Unified Patent Court affordable for small biotechs?The Unified Patent Court and the unitary patent were established to make patent litigation in Europe easier, faster and more affordable. It has been particularly emphasized that the new system was designed … more ➔
Alexander Sievert Photography Cell TherapyPL BioScience: Pioneering the Future of Cell CultureWith the promise of transformative treatments, cell therapies are rising across oncology, regenerative medicine, and stem cell applications. PL BioScience supports this evolution with Human Platelet … more ➔
Bayer Co.LabIncubatorBerlin: Why Start-ups Choose Bayer Co.LabOne year after the inauguration of Bayer Co.Lab — the open workspace for start-ups in Berlin — it is time to take stock. European Biotechnology News Magazine spoke with tenants and with Dr Ruth … more ➔
Yumab GmbHADCAntibodies: Cornerstone of ADC precision and efficacyAntibody-drug conjugates (ADCs) hinge on the antibody, not merely the payload or linker. Antibody precision defines efficacy, safety and therapeutic window. Emerging antibody formats – bispecifics, … more ➔
Concept Heidelberg GmbHBioanalyticsFrom method validation to the life-cycleEarlier guidelines such as ICH Q2(R1) and USP , , and viewed analytical method validation as a discrete activity focused primarily on chromatographic procedures. With ICH Q14, ICH Q2(R2), and USP , … more ➔
www.istockphoto.com/Yuri
SLAS
VanessaSpencer - stock.adobe.com
Kelli McClintock auf Unsplash
Cencora
Boehmert & Boehmert
Alexander Sievert Photography 
Bayer Co.Lab
Yumab GmbH
Concept Heidelberg GmbH